Dr. Lin on Combination Atezolizumab and Chemoradiation in Locally Advanced NSCLC

Cancer Network spoke with Steven H. Lin, MD, PhD, associate professor and radiation oncologist at The University of Texas MD Anderson Cancer Center, on the findings of a phase II trial (abstract 8512) combining atezolizumab with chemoradiation therapy in locally advanced non-small-cell lung cancer. The results were presented at ASCO 2019 in Chicago.